• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 在肌病中的作用:发病率、病因、治疗和预防。

The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention.

机构信息

Department of Family Physician (CCFP), Madigan Medical Centre, Calgary, Alberta, Canada.

Department of Pharmacology, College of Medicine, University of Baghdad, Baghdad, Iraq.

出版信息

J Med Life. 2022 Dec;15(12):1458-1463. doi: 10.25122/jml-2022-0167.

DOI:10.25122/jml-2022-0167
PMID:36762328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9884359/
Abstract

Myopathy is a disease characterized by muscle dysfunction in general and may be associated with genetics, medication such as statins, or inflammation. In 2019, an epidemic viral infection (SARS-CoV-2 virus) that invaded most countries worldwide appeared and caused acute respiratory disease. Consequently, patients had to take a group of drugs for a relatively long treatment period. According to several studies, there was an increase in the cases of muscular disorders due to several factors. This study aimed to (1) investigate the relationship between COVID-19 and myopathy and (2) identify the causes and prevention methods. A systematic review was conducted, analyzing several articles from the following databases: ResearchGate, Medline, DOAJ (The Directory of Open-Access Journals), PubMed, and Google Scholar. After performing the search and filtering the results, we included 61 articles. There was a strong relationship between COVID-19 and myopathy, especially in patients admitted to the ICU department, due to medication or neurological dysregulation with multiorgan dysfunctions such as polyneuropathy, peripheral nerve involvement, dysautonomia, Guillain-Barré syndrome, and many others.

摘要

肌病是一种以肌肉功能障碍为特征的疾病,可能与遗传、他汀类药物等药物或炎症有关。2019 年,一种侵袭世界大多数国家的流行病毒(SARS-CoV-2 病毒)出现,导致急性呼吸道疾病。因此,患者需要服用一组药物进行相对较长的治疗期。根据几项研究,由于多种因素,肌肉疾病的病例有所增加。本研究旨在 (1) 研究 COVID-19 与肌病之间的关系,(2) 确定病因和预防方法。进行了系统评价,分析了来自以下数据库的几篇文章:ResearchGate、Medline、DOAJ(开放获取期刊目录)、PubMed 和 Google Scholar。在进行搜索和过滤结果后,我们纳入了 61 篇文章。COVID-19 与肌病之间存在很强的关系,特别是在因药物或神经调节紊乱导致多器官功能障碍(如多发性神经病、周围神经受累、自主神经功能障碍、吉兰-巴雷综合征等)而入住 ICU 病房的患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/9884359/3db9bb722c34/JMedLife-15-1458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/9884359/a04b819cf9d6/JMedLife-15-1458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/9884359/3db9bb722c34/JMedLife-15-1458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/9884359/a04b819cf9d6/JMedLife-15-1458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b947/9884359/3db9bb722c34/JMedLife-15-1458-g002.jpg

相似文献

1
The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention.COVID-19 在肌病中的作用:发病率、病因、治疗和预防。
J Med Life. 2022 Dec;15(12):1458-1463. doi: 10.25122/jml-2022-0167.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.
6
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
7
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染(包括艾滋病毒感染)的干预措施。
Cochrane Database Syst Rev. 2001(2):CD001220. doi: 10.1002/14651858.CD001220.
10
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.

引用本文的文献

1
Performance of Risk Scores in SARS-CoV-2 Infection: A Retrospective Study.SARS-CoV-2感染风险评分的表现:一项回顾性研究
Int J Environ Res Public Health. 2025 Jul 23;22(8):1166. doi: 10.3390/ijerph22081166.
2
Theoretical biological activities and docking studies of new derivatives of acyclovir for the treatment of coronavirus disease 2019.阿昔洛韦新衍生物治疗2019冠状病毒病的理论生物学活性及对接研究
J Med Life. 2024 Sep;17(9):840-847. doi: 10.25122/jml-2023-0335.
3
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations.

本文引用的文献

1
Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID.抗氧化基因谱改变了长期新冠后出现神经后遗症的概率。
Antioxidants (Basel). 2022 May 12;11(5):954. doi: 10.3390/antiox11050954.
2
Impact of Covid-19 pandemic on a general surgery clinic.Covid-19 大流行对普外科门诊的影响。
J Med Life. 2022 Mar;15(3):415-419. doi: 10.25122/jml-2022-0087.
3
Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation.揭示与新冠病毒相关的肌肉损伤以及3D培养在其研究中的作用。
小鼠新冠后急性后遗症中的持续性神经功能缺损揭示了抗病毒药物的局限性
bioRxiv. 2024 Jun 3:2024.06.02.596989. doi: 10.1101/2024.06.02.596989.
4
Statin-Associated Liver Dysfunction and Muscle Injury: epidemiology, Mechanisms, and Management Strategies.他汀类药物相关的肝功能障碍和肌肉损伤:流行病学、机制及管理策略
Int J Gen Med. 2024 May 11;17:2055-2063. doi: 10.2147/IJGM.S460305. eCollection 2024.
5
Variations of blood viscosity in acute typhoid fever: A cross-sectional study.急性伤寒热患者血液粘度的变化:一项横断面研究。
J Med Life. 2023 Oct;16(10):1448-1451. doi: 10.25122/jml-2023-0027.
6
Potential anti-obesity effects of two-graded doses of Iraqi leaves extract, alone and in combination with orlistat, on high-fat diet-induced obesity in male rats.伊拉克叶提取物两阶段剂量单独及与奥利司他联合应用对高脂饮食诱导肥胖雄性大鼠的潜在抗肥胖作用。
J Med Life. 2023 Sep;16(9):1338-1342. doi: 10.25122/jml-2023-0140.
7
Clinical Characteristics Profile of COVID-19 Patients with Omicron Variant Admitted in a Tertiary Hospital, Central China.华中地区一家三级医院收治的奥密克戎变异株新冠病毒感染患者的临床特征分析
Int J Gen Med. 2023 Jun 9;16:2365-2371. doi: 10.2147/IJGM.S409478. eCollection 2023.
8
Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs.化疗引起的心脏毒性:地高辛、ATG7 激活剂、白藜芦醇和草药药物作用的新视角。
J Med Life. 2023 Apr;16(4):491-500. doi: 10.25122/jml-2022-0322.
Front Nutr. 2022 Feb 10;9:825629. doi: 10.3389/fnut.2022.825629. eCollection 2022.
4
Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review.危重症幸存者的重症监护后综合征,包括新冠肺炎患者:一篇叙述性综述
Life (Basel). 2022 Jan 12;12(1):107. doi: 10.3390/life12010107.
5
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.中性粒细胞胞外陷阱 (NETs) 与新冠病毒 2019 (Covid-19):治疗模式的新前沿。
Int Immunopharmacol. 2022 Mar;104:108516. doi: 10.1016/j.intimp.2021.108516. Epub 2022 Jan 6.
6
Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions.瘦素激素及其在生殖、代谢、免疫、糖尿病方面的作用、希望和抱负。
J Med Life. 2021 Sep-Oct;14(5):600-605. doi: 10.25122/jml-2021-0153.
7
Critical Illness Polyneuropathy and Functional Outcome in Subjects with Covid-19: Report on Four Patients and a Scoping Review of the Literature.新冠肺炎患者的危重病性多发性神经病与功能结局:4 例患者报告及文献综述
J Rehabil Med. 2022 Apr 7;54:jrm00257. doi: 10.2340/jrm.v53.1139.
8
SARS-CoV-2 involvement in central nervous system tissue damage.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与中枢神经系统组织损伤有关。
Neural Regen Res. 2022 Jun;17(6):1228-1239. doi: 10.4103/1673-5374.327323.
9
Angiotensin II inhibition: a potential treatment to slow the progression of sarcopenia.血管紧张素 II 抑制:一种减缓肌肉减少症进展的潜在治疗方法。
Clin Sci (Lond). 2021 Nov 12;135(21):2503-2520. doi: 10.1042/CS20210719.
10
Skeletal muscle immunohistochemistry of acquired and hereditary myopathies.获得性和遗传性肌病的骨骼肌免疫组织化学。
Curr Opin Rheumatol. 2021 Nov 1;33(6):529-536. doi: 10.1097/BOR.0000000000000828.